Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Provell Pharmaceuticals Partners with Mark Cuban's Cost Plus Drug Co.

Apr 04, 2025•over 1 year ago

Contract Type

partnership

Honey BrookHealthcare

Description

Provell Pharmaceuticals, a distributor of branded drug products at generic prices, has filed for Chapter 7 bankruptcy with a plan to liquidate its assets. However, prior to this, the company formed a partnership with Mark Cuban Cost Plus Drug Co. to offer patients direct access to a leading hypothyroid drug, Euthyrox, at low-cost prices.

Company Information

Company

Provell Pharmaceuticals

Location

1801 Horseshoe Pike

Honey Brook, Pennsylvania, United States

About

We are a private healthcare company specializing in the marketing and distribution of world class leading pharmaceutical products in the United States. Our goal is to provide unique and innovative delivery of pharmaceutical products enhancing drug quality/stability, better patient adherence and outcomes, all at a lower cost.

Related People

Suggested for you
Steve
Likely contact at this company
••••••••@••••••••

See Steve's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Provell Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Provell Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.